Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction

Abstract Aims Murine models implicate phosphodiesterase 9A (PDE9A) as a nitric oxide‐independent regulator of cyclic guanosine monophosphate and promising novel therapeutic target in heart failure (HF) with preserved ejection fraction (HFpEF). This study describes PDE9A expression in endomyocardial...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Christian Besler, Karl‐Philipp Rommel, Karl‐Patrik Kresoja, Justus Mörbitz, Holger Kirsten, Markus Scholz, Karin Klingel, Joachim Thiery, Ralph Burkhardt, Petra Büttner, Volker Adams, Holger Thiele, Philipp Lurz
Format:	Artigo
Sprog:	Inglês
Udgivet:	Oxford University Press 2021-06-01
Serier:	ESC Heart Failure
Fag:	Phosphodiesterase 9A Heart failure Heart failure with preserved ejection fraction Fibrosis Inflammation
Online adgang:	https://doi.org/10.1002/ehf2.13327
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!